IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.
Leslie AR, Ning S, Armstrong CM, D'Abronzo LS, Sharifi M, Schaaf ZA, Lou W, Liu C, Evans CP, Lombard AP, Gao AC.
Leslie AR, et al. Among authors: gao ac.
iScience. 2024 Jan 20;27(2):108984. doi: 10.1016/j.isci.2024.108984. eCollection 2024 Feb 16.
iScience. 2024.
PMID: 38327800
Free PMC article.